Phenotypic Segment by Method to Account Larger Share in Microbial Identification Methods Market during 2022–2030

According to our latest study on “Microbial Identification Methods Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis" the market is expected to grow from US$ 4,882.85 million in 2022 and is expected to reach US$ 8,164.74 million by 2030; it is anticipated to record a CAGR of 6.64% from 2022 to 2030. The report highlights the key factors driving the microbial identification methods market growth and prominent players with their developments in the market.

Microbial identification is the characterization of microbes using a limited spectrum of pre-chosen tests appropriate to the studied problem. Microbial identification results help to decode the root of operational decisions. Therefore, it’s important to use accurate and reproducible microbial identification methods. The widely used methods for microbial identification are phenotypic, genotypic, and proteotypic.

The microbial identification methods market, by method, is segmented into genotypic, phenotypic, and proteotypic. The phenotypic segment held a larger market share in 2022. The phenotypic methods are often called the "traditional" method for microbial identification. The phenotypic method for microbial identification relies on metabolic variations across species to identify microorganisms. This method generally includes techniques such as Gram staining, culture, and biochemical assays. Furthermore, genotypic segment is anticipated to register a higher CAGR from 2022 to 2030.

The microbial identification methods market, by type, is segmented into bacterial identification systems, microbial enumeration systems, bacterial resistance identification systems, microbiology analyzers, and others. The bacterial identification system segment held a largest market share in 2022 and same segment is anticipated to register a highest CAGR during 2022-2030.

Avantor Inc, Becton Dickinson and Co, bioMerieux SA, Merck KGaA, Thermo Fisher Scientific Inc, Bruker Corp, Shimadzu Corp, Accelerate Diagnostics Inc, Molzym GmbH & Co KG, and Biolog Inc are among the leading companies operating in the global Microbial Identification Methods market.    

Companies operating in the microbial identification methods market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the microbial identification methods market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall microbial identification methods market growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.

A few of the significant developments by key market players are listed below.

• In June 2023, Biolog, Inc., announced the launch of the Odin system, an all-in-one cellular phenotyping and microbial identification platform. Odin is compatible with all Biolog assays.
• In April 2023, Bruker Corporation launched the fast next-generation MALDI Biotyper IVD Software and optimized MBT Mycobacteria IVD Kit and MBT HT Filamentous Fungi IVD Module. The launch is expected to complement company's user-friendly, best-in-class diagnostic solutions for routine clinical microbiology and infection diagnostics laboratories.
• In January 2023, Biolog Inc, announced the acquisition of MIDI Labs and MIDI, Inc., both headquartered in Newark, Delaware. Biolog and MIDI serve many of the same customers and industries. Over the last two decades, both companies have served the microbial ID community offering complimentary products and services. MIDI Labs is an innovator in microbial identification which currently offers contract laboratory services for microbial identification and enumeration to deliver critical, time-sensitive ID for pharmaceutical, probiotic, food and beverage, and personal care manufacturing operations using sequencing and MALDI-TOF mass spectrometry. 
• In July 2022, Accelerate Diagnostics Inc announced CE marking of its new Accelerate Arc Module and BC kit. Designed for labs with MALDI platforms, the Accelerate Arc Module and BC kit is a novel application of inline centrifugation and automated sample prep techniques, which together with the blood culture (BC) kit, provides a suspension of cleaned microbial cells for direct transfer to a MALDI spotting plate.
• In September 2021, Avantor announced a global distribution agreement with Oxford Nanopore Technologies, a market leading manufacturer of Next Generation Sequencing instruments, kits, and consumables. The agreement enables scientists to have broader access to Oxford Nanopore’s portable real-time nanopore sequencing device, MinION, associated consumables and reagents.

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com